Skip to main content
Top
Published in: Acta Diabetologica 4/2016

01-08-2016 | Original Article

Phosphorylation of MafA enhances interaction with Beta2/NeuroD1

Authors: Song-iee Han, Yukino Tsunekage, Kohsuke Kataoka

Published in: Acta Diabetologica | Issue 4/2016

Login to get access

Abstract

Aims

MafA is a critical regulator of insulin expression and mature β-cell function. MafA binds to the insulin promoter through its carboxyl-terminal basic domain-leucine zipper (bZip) region and activates transcription synergistically with the β-cell-enriched transactivators Beta2 (NeuroD1) and Pdx1. MafA protein is highly phosphorylated in β-cells, and phosphorylation at multiple sites within its amino-terminal region is critical for its DNA-binding and transactivating abilities, as well as for regulation of its degradation. Here, we investigated whether phosphorylation of MafA affects its interaction with Beta2.

Methods

By mutational analysis, we identified interaction domains of MafA and Beta2. Using in situ proximity ligation assay (PLA), we explored mechanism of phosphorylation-dependent binding of MafA with Beta2. We also searched for a pathophysiological condition that would induce lower levels of MafA phosphorylation.

Results

Mutational analysis revealed that the phosphorylation sites within the amino-terminal region of MafA were not necessary for interaction with Beta2. In situ PLA suggested that phosphorylation induces conformational or configurational changes in MafA, thereby regulating the interaction with Beta2. We also found that long-term culture of the MIN6 insulinoma cell line under high-glucose conditions resulted in a decrease in β-cell-specific transcripts including insulin, along with a decrease in MafA phosphorylation and DNA binding.

Conclusion

Phosphorylation of MafA plays a critical role in β-cell function by regulating multiple functionalities, including binding to DNA, interaction with Beta2, and transactivation.
Literature
1.
go back to reference Olbrot M, Rud J, Moss LG, Sharma A (2002) Identification of β-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA. Proc Natl Acad Sci USA 99:6737–6742CrossRefPubMedPubMedCentral Olbrot M, Rud J, Moss LG, Sharma A (2002) Identification of β-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA. Proc Natl Acad Sci USA 99:6737–6742CrossRefPubMedPubMedCentral
2.
go back to reference Kataoka K, Han S-I, Shioda S et al (2002) MafA is a glucose-regulated and pancreatic β-cell-specific transcriptional activator for the insulin gene. J Biol Chem 277:49903–49910CrossRefPubMed Kataoka K, Han S-I, Shioda S et al (2002) MafA is a glucose-regulated and pancreatic β-cell-specific transcriptional activator for the insulin gene. J Biol Chem 277:49903–49910CrossRefPubMed
3.
go back to reference Matsuoka T, Zhao L, Artner I et al (2003) Members of the large Maf transcription family regulate insulin gene transcription in islet β cells. Mol Cell Biol 23:6049–6062CrossRefPubMedPubMedCentral Matsuoka T, Zhao L, Artner I et al (2003) Members of the large Maf transcription family regulate insulin gene transcription in islet β cells. Mol Cell Biol 23:6049–6062CrossRefPubMedPubMedCentral
4.
go back to reference Docherty HM, Hay CW, Ferguson LA et al (2005) Relative contribution of PDX-1, MafA and E47/β2 to the regulation of the human insulin promoter. Biochem J 389:813–820CrossRefPubMedPubMedCentral Docherty HM, Hay CW, Ferguson LA et al (2005) Relative contribution of PDX-1, MafA and E47/β2 to the regulation of the human insulin promoter. Biochem J 389:813–820CrossRefPubMedPubMedCentral
5.
go back to reference Aramata S, Han S-I, Yasuda K, Kataoka K (2005) Synergistic activation of the insulin gene promoter by the β-cell enriched transcription factors MafA, Beta2, and Pdx1. Biochim Biophys Acta 1730:41–46CrossRefPubMed Aramata S, Han S-I, Yasuda K, Kataoka K (2005) Synergistic activation of the insulin gene promoter by the β-cell enriched transcription factors MafA, Beta2, and Pdx1. Biochim Biophys Acta 1730:41–46CrossRefPubMed
6.
go back to reference Kaneto H, Matsuoka T, Nakatani Y et al (2005) A crucial role of MafA as a novel therapeutic target for diabetes. J Biol Chem 280:15047–15052CrossRefPubMed Kaneto H, Matsuoka T, Nakatani Y et al (2005) A crucial role of MafA as a novel therapeutic target for diabetes. J Biol Chem 280:15047–15052CrossRefPubMed
7.
go back to reference Zhao L, Guo M, Matsuoka TA et al (2005) The islet β cell-enriched MafA activator is a key regulator of insulin gene transcription. J Biol Chem 280:11887–11894CrossRefPubMed Zhao L, Guo M, Matsuoka TA et al (2005) The islet β cell-enriched MafA activator is a key regulator of insulin gene transcription. J Biol Chem 280:11887–11894CrossRefPubMed
8.
go back to reference Wang H, Brun T, Kataoka K et al (2007) MafA controls genes implicated in insulin biosynthesis and secretion. Diabetologia 50:348–358CrossRefPubMed Wang H, Brun T, Kataoka K et al (2007) MafA controls genes implicated in insulin biosynthesis and secretion. Diabetologia 50:348–358CrossRefPubMed
9.
go back to reference Matsuoka T, Kaneto H, Stein R et al (2007) MafA regulates expression of genes important to islet β-cell function. Mol Endocrinol 21:2764–2774CrossRefPubMed Matsuoka T, Kaneto H, Stein R et al (2007) MafA regulates expression of genes important to islet β-cell function. Mol Endocrinol 21:2764–2774CrossRefPubMed
10.
11.
12.
13.
go back to reference Matsuoka T, Kaneto H, Kawashima S et al (2015) Preserving Mafa expression in diabetic islet β-cells improves glycemic control in vivo. J Biol Chem 290:7647–7657CrossRefPubMedPubMedCentral Matsuoka T, Kaneto H, Kawashima S et al (2015) Preserving Mafa expression in diabetic islet β-cells improves glycemic control in vivo. J Biol Chem 290:7647–7657CrossRefPubMedPubMedCentral
14.
go back to reference Sharma A, Olson LK, Robertson RP, Stein R (1995) The reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to high glucose concentration is associated with the loss of RIPE3b1 and STF-1 transcription factor expression. Mol Endocrinol 9:1127–1134PubMed Sharma A, Olson LK, Robertson RP, Stein R (1995) The reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to high glucose concentration is associated with the loss of RIPE3b1 and STF-1 transcription factor expression. Mol Endocrinol 9:1127–1134PubMed
15.
go back to reference Harmon JS, Tanaka Y, Olson LK, Robertson RP (1998) Reconstitution of glucotoxic HIT-T15 cells with somatostatin transcription factor-1 partially restores insulin promoter activity. Diabetes 47:900–904CrossRefPubMed Harmon JS, Tanaka Y, Olson LK, Robertson RP (1998) Reconstitution of glucotoxic HIT-T15 cells with somatostatin transcription factor-1 partially restores insulin promoter activity. Diabetes 47:900–904CrossRefPubMed
16.
go back to reference Poitout V, Olson LK, Robertson RP (1996) Chronic exposure of βTC-6 cells to supraphysiologic concentrations of glucose decreases binding of the RIPE3b1 insulin gene transcription activator. J Clin Investig 97:1041–1046CrossRefPubMedPubMedCentral Poitout V, Olson LK, Robertson RP (1996) Chronic exposure of βTC-6 cells to supraphysiologic concentrations of glucose decreases binding of the RIPE3b1 insulin gene transcription activator. J Clin Investig 97:1041–1046CrossRefPubMedPubMedCentral
17.
go back to reference Lu X, Guanga GP, Wan C, Rose RB (2012) A novel DNA binding mechanism for maf basic region-leucine zipper factors Inferred from a MafA–DNA complex structure and binding specificities. Biochemistry 51:9706–9717CrossRefPubMed Lu X, Guanga GP, Wan C, Rose RB (2012) A novel DNA binding mechanism for maf basic region-leucine zipper factors Inferred from a MafA–DNA complex structure and binding specificities. Biochemistry 51:9706–9717CrossRefPubMed
18.
go back to reference Kanai K, Reza HM, Kamitani A et al (2010) SUMOylation negatively regulates transcriptional and oncogenic activities of MafA. Genes Cells 15:971–982CrossRefPubMed Kanai K, Reza HM, Kamitani A et al (2010) SUMOylation negatively regulates transcriptional and oncogenic activities of MafA. Genes Cells 15:971–982CrossRefPubMed
20.
go back to reference Han S-I, Aramata S, Yasuda K, Kataoka K (2007) MafA stability in pancreatic β-cells is regulated by glucose and is dependent on its constitutive phosphorylation at multiple sites by glycogen synthase kinase 3. Mol Cell Biol 27:6593–6605CrossRefPubMedPubMedCentral Han S-I, Aramata S, Yasuda K, Kataoka K (2007) MafA stability in pancreatic β-cells is regulated by glucose and is dependent on its constitutive phosphorylation at multiple sites by glycogen synthase kinase 3. Mol Cell Biol 27:6593–6605CrossRefPubMedPubMedCentral
21.
go back to reference Rocques N, Abou Zeid N, Sii-Felice K et al (2007) GSK-3-mediated phosphorylation enhances maf-transforming activity. Mol Cell 28:584–597CrossRefPubMed Rocques N, Abou Zeid N, Sii-Felice K et al (2007) GSK-3-mediated phosphorylation enhances maf-transforming activity. Mol Cell 28:584–597CrossRefPubMed
22.
go back to reference Sii-Felice K, Pouponnot C, Gillet S et al (2005) MafA transcription factor is phosphorylated by p38 MAP kinase. FEBS Lett 579:3547–3554CrossRefPubMed Sii-Felice K, Pouponnot C, Gillet S et al (2005) MafA transcription factor is phosphorylated by p38 MAP kinase. FEBS Lett 579:3547–3554CrossRefPubMed
23.
go back to reference Guo S, Vanderford NL, Stein R (2010) Phosphorylation within the MafA N terminus regulates C-terminal dimerization and DNA binding. J Biol Chem 285:12655–12661CrossRefPubMedPubMedCentral Guo S, Vanderford NL, Stein R (2010) Phosphorylation within the MafA N terminus regulates C-terminal dimerization and DNA binding. J Biol Chem 285:12655–12661CrossRefPubMedPubMedCentral
24.
go back to reference Kanai K, Aramata S, Katakami S et al (2011) Proteasome activator PA28γ stimulates degradation of GSK3-phosphorylated insulin transcription activator MAFA. J Mol Endocrinol 47:119–127CrossRef Kanai K, Aramata S, Katakami S et al (2011) Proteasome activator PA28γ stimulates degradation of GSK3-phosphorylated insulin transcription activator MAFA. J Mol Endocrinol 47:119–127CrossRef
25.
go back to reference Naya FJ, Stellrecht CM, Tsai MJ (1995) Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor. Genes Dev 9:1009–1019CrossRefPubMed Naya FJ, Stellrecht CM, Tsai MJ (1995) Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor. Genes Dev 9:1009–1019CrossRefPubMed
26.
go back to reference Miyazaki JI, Araki K, Yamato E et al (1990) Establishment of a pancreatic β cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127:126–132CrossRefPubMed Miyazaki JI, Araki K, Yamato E et al (1990) Establishment of a pancreatic β cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127:126–132CrossRefPubMed
27.
go back to reference Han S-I, Yasuda K, Kataoka K (2011) ATF2 interacts with β-cell-enriched transcription factors, MafA, Pdx1, and Beta2, and activates insulin gene transcription. J Biol Chem 286:10449–10456CrossRefPubMedPubMedCentral Han S-I, Yasuda K, Kataoka K (2011) ATF2 interacts with β-cell-enriched transcription factors, MafA, Pdx1, and Beta2, and activates insulin gene transcription. J Biol Chem 286:10449–10456CrossRefPubMedPubMedCentral
28.
go back to reference Jakobsson T, Venteclef N, Toresson G et al (2009) GPS2 is required for cholesterol efflux by triggering histone demethylation, LXR recruitment, and coregulator assembly at the ABCG1 locus. Mol Cell 34:510–518CrossRefPubMed Jakobsson T, Venteclef N, Toresson G et al (2009) GPS2 is required for cholesterol efflux by triggering histone demethylation, LXR recruitment, and coregulator assembly at the ABCG1 locus. Mol Cell 34:510–518CrossRefPubMed
29.
go back to reference Yamato E, Tashiro F, Miyazaki J (2013) Microarray analysis of novel candidate genes responsible for glucose-stimulated insulin secretion in mouse pancreatic β cell line MIN6. PLoS One 8:e61211CrossRefPubMedPubMedCentral Yamato E, Tashiro F, Miyazaki J (2013) Microarray analysis of novel candidate genes responsible for glucose-stimulated insulin secretion in mouse pancreatic β cell line MIN6. PLoS One 8:e61211CrossRefPubMedPubMedCentral
Metadata
Title
Phosphorylation of MafA enhances interaction with Beta2/NeuroD1
Authors
Song-iee Han
Yukino Tsunekage
Kohsuke Kataoka
Publication date
01-08-2016
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 4/2016
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-016-0853-1

Other articles of this Issue 4/2016

Acta Diabetologica 4/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.